Compounds > silybin
Page last updated: 2024-08-23

silybin and Carcinoma, Basal Cell

silybin has been researched along with Carcinoma, Basal Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Agarwal, C; Agarwal, R; Deep, G; Kant, R; Maurya, A; Orlicky, DJ; Paudel, S; Raina, B; Raina, K; Rigby, CM; Tiku, VR; You, Z1
Agarwal, C; Agarwal, R; Deep, G; Jain, A; Orlicky, DJ; Rigby, C1
Agarwal, C; Agarwal, R; Biedermann, D; Deep, G; Kren, V; Tilley, C; Valentová, K; Wempe, MF1
Agarwal, R; Deep, G; Tilley, C1
Agarwal, C; Agarwal, R; Deep, G; Dheeraj, A; O'Bryant, CL; Rigby, CM; Singh, RP1

Reviews

1 review(s) available for silybin and Carcinoma, Basal Cell

ArticleYear
Chemopreventive opportunities to control basal cell carcinoma: Current perspectives.
    Molecular carcinogenesis, 2015, Volume: 54, Issue:9

    Topics: Animals; Antioxidants; Biological Products; Carcinoma, Basal Cell; Hedgehog Proteins; Humans; Silybin; Silymarin; Skin; Skin Neoplasms

2015

Other Studies

4 other study(ies) available for silybin and Carcinoma, Basal Cell

ArticleYear
Chemopreventive efficacy of silibinin against basal cell carcinoma growth and progression in UVB-irradiated Ptch+/- mice.
    Carcinogenesis, 2022, 06-27, Volume: 43, Issue:6

    Topics: Animals; Carcinoma, Basal Cell; Female; Hedgehog Proteins; Male; Mice; Patched-1 Receptor; Silybin; Skin Neoplasms; Ultraviolet Rays

2022
Silibinin inhibits ultraviolet B radiation-induced mast cells recruitment and bone morphogenetic protein 2 expression in the skin at early stages in Ptch(+/-) mouse model of basal cell carcinoma.
    Molecular carcinogenesis, 2019, Volume: 58, Issue:7

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Bone Morphogenetic Protein 2; Carcinoma, Basal Cell; Chemoprevention; Cyclin D1; Disease Models, Animal; DNA Damage; Mast Cells; Mice; Mice, Transgenic; Patched-1 Receptor; Signal Transduction; Silybin; Skin; Skin Neoplasms; Tumor Suppressor Proteins; Ultraviolet Rays

2019
Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.
    Molecular carcinogenesis, 2016, Volume: 55, Issue:1

    Topics: Allografts; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Basal Cell; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Enzyme Activation; Humans; Mice; Mice, Knockout; NF-kappa B; Signal Transduction; Silybin; Silymarin; Skin Neoplasms; Transcription Factor AP-1; Transcription Factors; Tumor Stem Cell Assay

2016
Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling.
    Photochemistry and photobiology, 2017, Volume: 93, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Hedgehog Proteins; Humans; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Silybin; Skin Neoplasms

2017